ArticleFrontiers in cellular and infection microbiology2025
Multi-omics approaches for image classification in disease diagnosis.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Is adenosine signalling entering the precision medicine era? From receptor pharmacology to patient stratification.Purinergic signalling · 2026Review
- Interpreting the Black Box: Interpretable Machine Learning and Systems Pharmacology in Small-Molecule Therapeutics.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The integration of multi-omics data for disease diagnosis holds transformative potential in the field of computational biology, especially when applied to the intricate and dynamic interactions between microbial communities and their human hosts. Methods: This integrative approach enables to capture diverse biological signals across genomic, transcriptomic, proteomic, and metabolomic layers, providing a more comprehensive understanding of disease mechanisms. In alignment with emerging priorities in disease microbiology, our study addresses a critical and timely need for interpretable, scalable, and biologically robust computational models that can extract clinically meaningful diagnostic insights from inherently high-dimensional, heterogeneous, and often incomplete biological datasets. Results and Discussion: Traditional image classification approaches in disease contexts-such as those relying solely on histopathological features or genomic imaging-tend to overlook the broader ecological and systemic dimensions that are essential for decoding the mechanisms of microbial pathogenesis. These single-modal methods often suffer from significant limitations, including reduced scalability to diverse clinical settings, poor generalizability across patient populations, and an inability to handle partially observed or biologically variable data. Such constraints diminish their effectiveness in precision diagnostics, disease subtyping, and therapeutic decision-making. By contrast, our approach emphasizes multi-modal integration and model interpretability, aiming to overcome these limitations and advance the development of next-generation diagnostic tools that are both clinically actionable and biologically grounded.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.